• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Core Scientific Inc. (Amendment)

    1/25/24 4:15:30 PM ET
    $CORZ
    Finance: Consumer Services
    Finance
    Get the next $CORZ alert in real time by email
    SC 13D/A 1 d545166dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Core Scientific, Inc.

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    21873J108

    (CUSIP Number)

    David Maryles

    Managing Director, Legal and Compliance

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

    (212) 810-5300

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    January 23, 2024

    (Date of Event which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 21873J108

     

     1.   

     NAMES OF REPORTING PERSONS

     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

     BlackRock, Inc.

     2.  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     (a) ☐  (b) ☒

     

     3.  

     SEC USE ONLY

     

     4.  

     SOURCE OF FUNDS (see instructions)

     

     OO

     5.  

     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

     

     ☐

     6.  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

        7.    

     SOLE VOTING POWER

     

     2,239,620

        8.   

     SHARED VOTING POWER

     

     0

        9.   

     SOLE DISPOSITIVE POWER

     

     2,239,620

       10.   

     SHARED DISPOSITIVE POWER

     

     0

    11.   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     2,239,620

    12.  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

     

     ☐ See Item 5 herein.

    13.  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     1.2%

    14.  

     TYPE OF REPORTING PERSON (see instructions)

     

     HC


    EXPLANATORY NOTE

    This Amendment No. 1 (this “Amendment No. 1”) amends and supplements the Schedule 13D filed with the Securities and Exchange Commission on November 27, 2023 (as so amended, the “Schedule 13D”), by BlackRock relating to the Common Stock of Core Scientific, Inc., a Delaware corporation (the “Issuer”). Except as specifically provided herein, this Amendment No. 1 does not modify any of the information previously reported on the Schedule 13D. Capitalized terms used but not otherwise defined in this Amendment No. 1 shall have the meanings ascribed to them in the Schedule 13D.

    On December 21, 2022, the Issuer and certain of its affiliates (collectively, the “Debtors”) filed voluntary petitions (the “Chapter 11 Cases”) in the United States Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”) seeking relief under Chapter 11 of Title 11 of the United States Code (the “Bankruptcy Code”). On January 15, 2024, the Debtors filed with the Bankruptcy Court an amended joint reorganization plan under the Bankruptcy Code related to the Chapter 11 Cases (the “Plan”), and on January 16, 2024, the Bankruptcy Court entered an order confirming the Plan (the “Confirmation Order”). On January 23, 2024, (the “Effective Date”), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases. On the Effective Date, in connection with the effectiveness of, and pursuant to the terms of, the Plan and the Confirmation Order, the Issuer’s common stock outstanding immediately before the Effective Date was canceled and is of no further force or effect, and the new organizational documents of the Company became effective, authorizing the issuance of new shares of common stock, par value $0.00001 per share.

    Item 3. Source and Amount of Funds or Other Consideration.

    The information in Item 3 is hereby amended by adding the following immediately before the last paragraph thereof:

    On January 23, 2024, BlackRock, in its role as the parent of the Advisory Subsidiaries in the capacity as investment advisers to certain client accounts, acquired beneficial ownership of 2,239,620 shares of the Issuer’s Common Stock. BlackRock also acquired approximately $19.5 million in aggregate principal amount of secured convertible notes that may be convertible into up to 3,346,958 shares of Common Stock in accordance with the terms of the indenture governing the convertible notes. Such securities were acquired on the Effective Date as part of the Plan in exchange for securities of the Issuer held by the Advisory Subsidiaries prior to the Effective Date that were canceled as part of the Plan and were made for investment purposes in the ordinary course of business of the Advisory Subsidiaries. In addition, on the Effective Date as part of the Plan, BlackRock, in its role as the parent of the Advisory Subsidiaries in the capacity as investment advisers to certain client accounts, acquired 2,192,027 contingent value rights that entitle the holders thereof to certain cash payments upon the occurrence of certain events as described in the Issuer’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on January 23, 2024 (the “January 23, 2024 8-K”). Certain of such client accounts are also serving as lenders under the Issuer’s credit and guaranty agreement, dated as of January 23, 2024, by and among the Company, as borrower, the guarantors named therein, the lenders party thereto and Wilmington Trust, National Association, as administrative agent and collateral agent, consisting of an $80 million first-lien credit facility as further described in the Issuer’s January 23, 2024 8-K.


    Item 4. Purpose of Transaction.

    The information in Item 4 is hereby amended by adding the following immediately before the penultimate paragraph thereof:

    On January 23, 2024, upon the occurrence of the Effective Date under the Plan, the Support Period (as defined in the Support Agreement) concluded in accordance with the terms of the Support Agreement. As a result of the foregoing, any “group,” as such term is used in Regulation 13D under the Act that may be deemed to have been formed with the other parties to the Support Agreement who beneficially owned shares of the Issuer’s Common Stock prior to the Effective Date of the Plan, terminated on January 23, 2024.

    Item 5. Interest in Securities of the Issuer.

    The information in Item 5(a), (b), (c) and (e) is hereby amended and restated in its entirety to read as follows:

    (a) and (b) The responses of BlackRock to Rows (7) through (11), and (13) of the cover page of this Amendment No. 1 are incorporated herein by reference. See Annex A for applicable information regarding Covered Persons.

    The aggregate percentage of shares of Common Stock reported as beneficially owned by BlackRock was calculated based on 184,998,580 shares of Common Stock issued and outstanding as of January 23, 2024, the Effective Date, after giving effect to the consummation of the Plan, as disclosed in the Issuer’s January 23, 2024 8-K.

    The Common Stock beneficially owned by BlackRock includes Common Stock beneficially owned by its Advisory Subsidiary, BlackRock Financial Management, Inc.

    (c) Except with respect to the issuance of securities as part of the Plan, as described in Item 3 above, there were no transactions in the Common Stock of the Issuer effected during the past 60 days by the persons identified in Item 2 above.

    (e) As of January 23, 2024, BlackRock does not beneficially own more than five percent of the Issuer’s Common Stock and, as a result of the expiration of the Support Period under the Support Agreement, may no longer be deemed to be a member of a “group” that beneficially owns more than five percent of the Issuer’s Common Stock.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: January 25, 2024

     

    BlackRock, Inc.
    By:  

    /s/ David Maryles

      Name: David Maryles
      Title: Attorney-in-Fact


    Annex A

    The following is a list of the executive officers and directors of BlackRock, Inc. (collectively, the “Covered Persons”), setting forth the present principal occupation or employment and the name, principal business and address of any corporation or other organization in which such employment is conducted and citizenship for each such person. Each Covered Person is a citizen of the United States, unless otherwise noted, and does not have any other principal occupation (outside of similar positions held with respect to other entities directly or indirectly managed or advised by BlackRock).

    Executive Officers

     

    Name   

    Position

      

    Business Address

      

    Citizenship

    Laurence D. Fink    Chairman and Chief Executive Officer   

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    Robert S. Kapito    President   

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    Rachel Lord   

    Senior Managing Director and Chair and

    Head of Asia Pacific

      

    BlackRock, Inc.

    16/F Champion Tower

    3 Garden Road Central, Hong Kong

       U.K.
    Robert L. Goldstein   

    Senior Managing Director and

    Chief Operating Officer

      

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    J. Richard Kushel   

    Senior Managing Director and

    Head of the Portfolio Management Group

      

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    Stephen Cohen   

    Senior Managing Director and

    Head of Europe, Middle East and Africa

      

    BlackRock, Inc.

    Drapers Gardens

    12 Throgmorton Avenue

    London EC2N 2DL

    United Kingdom

       U.K.
    Christopher J. Meade    Senior Managing Director, Chief Legal Officer and General Counsel   

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    Martin Small   

    Senior Managing Director and

    Chief Financial Officer

      

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    Mark Wiedman   

    Senior Managing Director and

    Head of the Global Client Business

      

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    Caroline Heller   

    Senior Managing Director and

    Global Head of Human Resources

      

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    Marc Comerchero    Managing Director, Chief Accounting Officer and Global Controller   

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.

     

    A-1


    Directors

     

    Name   

    Principal Occupation or Employment

      

    Business Address

      

    Citizenship

    Bader M. Alsaad    Arab Fund for Economic & Social Development – Chairman of the Board and Director General   

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       Kuwait
    Pamela Daley    General Electric Company – Former Senior Vice President of Corporate Business Development   

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    Laurence D. Fink    BlackRock, Inc. – Chairman and Chief Executive Officer   

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    William E. Ford    General Atlantic – Chairman and Chief Executive Officer   

    General Atlantic

    Park Avenue Plaza

    50 Hudson Yards, 33rd Fl

    New York, NY 10001

       U.S.
    Fabrizio Freda    The Estée Lauder Companies Inc. – President and Chief Executive Officer   

    Estée Lauder Companies

    767 Fifth Avenue

    New York, NY 10153

       Italy & U.S.
    Murry S. Gerber    EQT Corporation – Former Executive Chairman, Chairman, President and Chief Executive Officer   

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    Margaret “Peggy” L. Johnson    Magic Leap, Inc. – Chief Executive Officer   

    Magic Leap

    7500 W. Sunrise Blvd

    Plantation, FL 33322

       U.S.
    Robert S. Kapito    BlackRock, Inc. – President   

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    Cheryl D. Mills   

    BlackIvy Group LLC – Founder and Chief

    Executive Officer

      

    BlackIvy Group LLC

    2300 N Street NW

    Suite 630

    Washington DC 20037

       U.S.
    Amin H. Nasser    Saudi Arabian Oil Company – President and Chief Executive Officer   

    P.O. Box 5000, Dhahran, 31311,

    Kingdom of Saudi Arabia

       Saudi Arabia
    Gordon M. Nixon    Royal Bank of Canada – Former President, Chief Executive Officer and Board Member   

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       Canada
    Kristin C. Peck    Zoetis Inc. – Chief Executive Officer   

    Zoetis Inc.

    10 Sylvan Way

    Parsippany, NJ 07054

       U.S.

     

    A-2


    Charles H. Robbins   

    Cisco Systems, Inc. – Chairman and Chief

    Executive Officer

      

    Cisco Systems, Inc.

    170 West Tasman Drive

    San Jose, CA 95134

       U.S.
    Marco Antonio Slim Domit    Grupo Financiero Inbursa, S.A.B. de C.V. – Chairman   

    Grupo Financiero Inbursa

    Av. Paseo de las Palmas, #736

    Floor 1

    Colonia Lomas de

    Chapultepec

    C.P. 11000, México D.F.

       Mexico
    Hans E. Vestberg    Verizon Communications Inc. – Chairman and Chief Executive Officer   

    Verizon Communications Inc.

    1095 Avenue of the Americas

    New York, NY 10036

       Sweden
    Susan L. Wagner    BlackRock, Inc. – Former Vice Chairman   

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       U.S.
    Mark Wilson    Abacai – Co-Chairman and Chief Executive Officer   

    BlackRock, Inc.

    50 Hudson Yards

    New York, NY 10001

       New Zealand
    Get the next $CORZ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CORZ

    DatePrice TargetRatingAnalyst
    1/27/2025$22.00Outperform
    Keefe Bruyette
    1/21/2025$24.00Buy
    Craig Hallum
    11/15/2024$25.50Buy
    ROTH MKM
    10/28/2024$19.00Buy
    Jefferies
    9/25/2024$16.00Outperform
    Macquarie
    9/23/2024$16.00Buy
    Canaccord Genuity
    9/4/2024$16.00Buy
    Needham
    7/17/2024$20.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $CORZ
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Core Scientific Announces Departure of Board Member Todd Becker

      Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced that Todd Becker will be stepping down from its Board of Directors, effective immediately. Mr. Becker joined the Board in January 2024 and has served as Chair of the Audit Committee. During his tenure, he provided critical leadership and oversight as Core Scientific completed two significant capital raises that materially improved the company's balance sheet, the hiring of a new Chief Financial Officer and supported its ongoing operational and strategic objectives following its emergence from bankruptcy. His financial acumen and disciplined

      5/13/25 4:42:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Core Scientific Announces Fiscal First Quarter 2025 Results

      First Quarter 2025 Highlights On track to deliver 250MW of billable capacity to CoreWeave by the end of this year and anticipate entering 2026 with annualized colocation revenue of approximately $360 million. First tranche of 8MW of billable capacity at Denton to be delivered to CoreWeave by the end of this month and an additional approximately 40MW by the end of this quarter. Ended the quarter with a strong liquidity position, including $778.6 million in cash and cash equivalents and digital assets, maintaining financial flexibility to execute on strategic organic and inorganic growth opportunities. Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-de

      5/7/25 4:05:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Core Scientific, Inc. Schedules First Quarter Fiscal Year 2025 Earnings Release, Conference Call and Webcast

      Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or "the Company"), a leader in digital infrastructure for high-performance computing and bitcoin mining, today announced it will issue financial results for the Company's fiscal year 2025 first quarter after financial markets close on Wednesday, May 7, 2025. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the first quarter 2025 will be Adam Sullivan, Chief Executive Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Vice President, Investor Relations. Conference Call and Webcast Event Summary Date: May 7

      4/24/25 4:10:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Keefe Bruyette initiated coverage on Core Scientific with a new price target

      Keefe Bruyette initiated coverage of Core Scientific with a rating of Outperform and set a new price target of $22.00

      1/27/25 7:37:53 AM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Craig Hallum initiated coverage on Core Scientific with a new price target

      Craig Hallum initiated coverage of Core Scientific with a rating of Buy and set a new price target of $24.00

      1/21/25 8:43:19 AM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • ROTH MKM initiated coverage on Core Scientific with a new price target

      ROTH MKM initiated coverage of Core Scientific with a rating of Buy and set a new price target of $25.50

      11/15/24 7:41:45 AM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Weiss Eric Stanton bought $50,750 worth of shares (6,000 units at $8.46), increasing direct ownership by 3% to 221,687 units (SEC Form 4)

      4 - Core Scientific, Inc./tx (0001839341) (Issuer)

      3/7/25 3:07:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Director Levy Jordan bought $500,506 worth of shares (62,500 units at $8.01), increasing direct ownership by 26% to 306,887 units (SEC Form 4)

      4 - Core Scientific, Inc./tx (0001839341) (Issuer)

      3/6/25 6:45:04 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Director Patten Jarrod M bought $24,752 worth of shares (2,240 units at $11.05), increasing direct ownership by 0.75% to 300,000 units (SEC Form 4)

      4 - Core Scientific, Inc./tx (0001839341) (Issuer)

      9/16/24 7:20:51 PM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    Financials

    Live finance-specific insights

    See more
    • Core Scientific Announces Fiscal First Quarter 2025 Results

      First Quarter 2025 Highlights On track to deliver 250MW of billable capacity to CoreWeave by the end of this year and anticipate entering 2026 with annualized colocation revenue of approximately $360 million. First tranche of 8MW of billable capacity at Denton to be delivered to CoreWeave by the end of this month and an additional approximately 40MW by the end of this quarter. Ended the quarter with a strong liquidity position, including $778.6 million in cash and cash equivalents and digital assets, maintaining financial flexibility to execute on strategic organic and inorganic growth opportunities. Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-de

      5/7/25 4:05:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Core Scientific, Inc. Schedules First Quarter Fiscal Year 2025 Earnings Release, Conference Call and Webcast

      Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or "the Company"), a leader in digital infrastructure for high-performance computing and bitcoin mining, today announced it will issue financial results for the Company's fiscal year 2025 first quarter after financial markets close on Wednesday, May 7, 2025. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the first quarter 2025 will be Adam Sullivan, Chief Executive Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Vice President, Investor Relations. Conference Call and Webcast Event Summary Date: May 7

      4/24/25 4:10:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Core Scientific Announces Fiscal Fourth Quarter and Full Fiscal Year 2024 Results

      Fourth Quarter 2024 Highlights Incurred net loss of $265.5 million due primarily to a $224.7 million non-cash mark-to-market adjustment to warrants and other contingent value right liabilities required by the significant year-over-year increase in our share price Reported operating loss of $39.8 million, a decrease of $43.7 million over fourth quarter 2023 Generated adjusted EBITDA of $13.3 million, a decrease of $43.4 million over fourth quarter 2023 Secured $625 million through a convertible note offering with favorable 0% interest terms Strengthened the balance sheet, ending the quarter with cash and cash equivalents of $836.2 million as of December 31, 2024 Earned 974

      2/26/25 4:05:00 PM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Duchene Todd M was granted 194,600 shares, increasing direct ownership by 10% to 2,210,102 units (SEC Form 4)

      4 - Core Scientific, Inc./tx (0001839341) (Issuer)

      4/30/25 7:34:10 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Chief Executive Officer Sullivan Adam Taylor was granted 665,985 shares, increasing direct ownership by 18% to 4,402,149 units (SEC Form 4)

      4 - Core Scientific, Inc./tx (0001839341) (Issuer)

      4/30/25 7:33:58 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Chief Executive Officer Sullivan Adam Taylor sold $170,213 worth of shares (22,629 units at $7.52), decreasing direct ownership by 0.60% to 3,736,164 units (SEC Form 4)

      4 - Core Scientific, Inc./tx (0001839341) (Issuer)

      4/2/25 4:27:41 PM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    SEC Filings

    See more
    • Core Scientific Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Core Scientific, Inc./tx (0001839341) (Filer)

      5/13/25 4:04:31 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • SEC Form 10-Q filed by Core Scientific Inc.

      10-Q - Core Scientific, Inc./tx (0001839341) (Filer)

      5/7/25 5:00:06 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • Core Scientific Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Core Scientific, Inc./tx (0001839341) (Filer)

      5/7/25 4:09:34 PM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Core Scientific Inc.

      SC 13G - Core Scientific, Inc./tx (0001839341) (Subject)

      8/19/24 7:14:21 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • SEC Form SC 13D/A filed by Core Scientific Inc. (Amendment)

      SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)

      2/21/24 4:43:56 PM ET
      $CORZ
      Finance: Consumer Services
      Finance
    • SEC Form SC 13D/A filed by Core Scientific Inc. (Amendment)

      SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)

      2/20/24 5:19:03 PM ET
      $CORZ
      Finance: Consumer Services
      Finance

    $CORZ
    Leadership Updates

    Live Leadership Updates

    See more
    • Core Scientific Announces Strategic Marketing Hire to Accelerate Growth and Brand Leadership

      Industry Veteran Scott Brueggeman Joins Core Scientific as Chief Marketing Officer to Drive Market Expansion and Visibility Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or "the Company"), a leader in digital infrastructure for high-performance computing and digital asset mining, today announced the appointment of Scott Brueggeman as Chief Marketing Officer. With over 20 years of experience in digital infrastructure and technology businesses, Brueggeman will play a pivotal role in strengthening the company's brand presence, driving growth, and expanding market opportunities. Brueggeman brings a proven track record of success in high-growth environments. Most recently, he served

      1/9/25 8:00:00 AM ET
      $CORZ
      Finance: Consumer Services
      Finance